GSK's Zofran Strengthens Cardiac Arrhythmia Warnings Pending QT Study Results
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is conducting a thorough QT study for the anti-emetic, the results of which should be available by mid-2012, FDA said.